Closing Bell: Cardiol Therapeutics Inc down on Wednesday (CRDL)
Cardiol Therapeutics Inc opened trading today at $3.26 and closed at $3.04. It traded at a low of $2.97 to a high of $3.26.
The price dipped -6.75 percent from the previous day's close of $3.26.
Today across North America, the TSX Composite closed -0.76% at 22639.57, the S&P 500 closed -0.16% at 5555.74, the Dow Jones Industrial Average closed -0.14% at 40358.09 and the Nasdaq Composite closed -0.06% at 17997.35.
Cardiol Therapeutics Inc traded under CRDL on the Toronto Stock Exchange (TSX).
A total of 161,449 shares was traded during the session, with total trades of 469, with an average volume of 142,697 over 5 days.
Trading across the entire TSX saw 1,249 price advancers against 3,959 declines and 110 unchanged.
During the prior 52 weeks, CRDL.TO has traded as high as $4.26 (June 12,2024) and low as $0.91 (October 23,2023). Moreover, the shares have risen 147.15 percent in 52 weeks, while they have risen 176.36% year-to-date.
Following today's trading, Cardiol Therapeutics Inc has a market capitalization of $226.22 million on a float of 69,391 shares outstanding. Its annual EPS is $-0.47.
Cardiol Therapeutics Inc is a TSX Drug Specialty & Generic company headquartered in Oakville, CAN.
Cardiol Therapeutics Inc's average recommendation is "Strong Sell" based on 0.00 analysts according to Zacks. Currently, there are for the stock.
AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..
